Neurodevelopmental Follow-up and Outcomes Research
The mission of the Neurodevelopmental Follow-Up and Outcomes Research group is to improve the quality of life of high-risk infants, particularly those born prematurely, and their families. The group also has a growing research interest in congenital heart disease and global child health. The group's research studies span two core themes:
- Develop a better understanding of long-term neurodevelopmental outcomes of high-risk infants.
- Discover the independent and interrelated roles of neurological and social processes underlying these neurodevelopmental outcomes.
The Neurodevelopmental Follow-Up and Outcomes Research group employs a range of methods in its studies including neurodevelopmental assessments, neuroimaging, parent and teacher reports, surveys and meta-analyses. The group also maintains collaboration with researchers at Harvard Medical School, Boston, USA; The Ohio State University College of Medicine, Columbus, USA; University of Canterbury, Christchurch, New Zealand; University of Cincinnati College of Medicine, Cincinnati, USA; University of Ghana Medical School, Accra, Ghana; University of Otago, Christchurch, New Zealand and Washington University School of Medicine, St. Louis, USA.
Group Members:
- Mr Benjamin Austin, PhD Candidate
- Ms Emma Sanders, Clinical Research Psychologist
- Mr Gautam Dagur, MD-PhD Candidate
- Ms Georgia Morris, Honours Candidate
- Ms Jemima Walker, Clinical Research Coordinator
- Ms Karen Eagleson, PhD Candidate
- Ms Victoria Gill, MD-PhD Candidate